➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Medtronic
Mallinckrodt
Merck
Moodys

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Details for Patent: 8,980,319

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,980,319 protect, and when does it expire?

Patent 8,980,319 protects XARTEMIS XR and is included in one NDA.

This patent has fifteen patent family members in eleven countries.

Summary for Patent: 8,980,319
Title:Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
Abstract: Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.
Inventor(s): Park; Jae Han (Olivette, MO), Eisenhauer; Tiffani (Columbia, IL), Dhanarajan; Anish (Metuchen, NJ), Gupta; Vishal (Hillsborough, NJ), Overholt; Stephen (Middlesex, NJ)
Assignee: Mallinckrodt LLC (Hazelwood, MO)
Application Number:14/092,375
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,980,319
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form;

Drugs Protected by US Patent 8,980,319

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mallinckrodt Inc XARTEMIS XR acetaminophen; oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 204031-001 Mar 11, 2014 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,980,319

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2011345329   Start Trial
Brazil 112013015622   Start Trial
Canada 2822553   Start Trial
China 103402499   Start Trial
European Patent Office 2654727   Start Trial
Japan 2014500315   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Moodys
Mallinckrodt
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.